Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

INTRODUCTION: Impaired renal function is a major complication of type 2 diabetes mellitus (T2DM). Mild renal impairment is present in 38% of patients with T2DM and may impact choice of antihyperglycemic agent. Sulfonylureas and dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used to treat hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ommen, Elizabeth S., Xu, Lei, O’Neill, Edward A., Goldstein, Barry J., Kaufman, Keith D., Engel, Samuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374078/
https://www.ncbi.nlm.nih.gov/pubmed/25633134
http://dx.doi.org/10.1007/s13300-015-0098-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374078/
https://www.ncbi.nlm.nih.gov/pubmed/25633134
http://dx.doi.org/10.1007/s13300-015-0098-y

Ejemplares similares